Genetically engineered models with alterations in cardiac membrane calcium-handling proteins

Annual Review of Physiology

Volumn 62, Issue , 2000, Pages 321-351

  Kiriazis, H ^a   Kranias, E G ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Ca2+ ATPase; Calsequestrin; Na+ Ca2+ exchanger; Phospholamban; Ryanodine receptor

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM; CELL MEMBRANE PROTEIN; FK 506 BINDING PROTEIN; PHOSPHOLAMBAN; RYANODINE RECEPTOR; SODIUM CALCIUM EXCHANGE PROTEIN;

CALCIUM CELL LEVEL; CALCIUM TRANSPORT; GENETIC ENGINEERING; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBER MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; REGULATORY MECHANISM; REVIEW; SARCOLEMMA; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; CALCIUM-BINDING PROTEINS; HEART; HUMANS; MEMBRANES; MYOCARDIUM; SARCOPLASMIC RETICULUM;

EID: 0033854532     PISSN: 00664278     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.physiol.62.1.321     Document Type: Review

References (86)

1. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure
2. 2+ ATPase genes: Homologies and mechanistic implications of deduced amino acid sequences
3. 2+-ATPase gene
4. 2+-ATPase
5. 2+- ATPase isoforms during ontogeny in the rat
6. 2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation
7. Sarcoplasmic reticulum function in murine ventricular myocytes overexpressing SR CaATPase
8. 2+-ATPase increases cardiac contractility in transgenic mouse hearts
9. 2+-ATPase isoform 2 (SERCA2) gene
10. 2+-ATPase
11. Adenosine 3':5'-monophosphate-dependent protein kinase-catalyzed phosphorylation reaction and its relationship to calcium transport in cardiac sarcoplasmic reticulum
12. Control of calcium transport in the myocardium by the cyclic AMP- protein kinase system
13. Concerted regulation of cardiac sarcoplasmic reticulum calcium transport by cyclic adenosine monophosphate-dependent and calcium- calmodulindependent phosphorylations
14. Mechanism of the stimulation of calcium ion dependent adenosine triphosphatase of cardiac sarcoplasmic reticulum by adenosine 3',5'- monophosphate dependent protein kinase
15. 2+)-activated ATPase activity in isolated cardiac sarcoplasmic reticulum
16. Regulation of cardiac sarcoplasmic reticulum calcium transport by calcium-calmodulin-dependent phosphorylation
17. Phosphorylation of phospholamban by calcium-activated, phospholipid- dependent protein kinase. Stimulation of cardiac sarcoplasmic reticulum calcium uptake
18. Mechanism by which cyclic adenosine 3':5'-monophosphate-dependent protein kinase stimulates calcium transport in cardiac sarcoplasmic reticulum
19. Effects of monoclonal antibody against phospholamban on calcium pump ATPase of cardiac sarcoplasmic reticulum
20. 2+ transport by cyclic 3',5'-AMP-dependent and calcium-calmodulin-dependent phosphorylation of cardiac sarcoplasmic reticulum
21. Phosphorylation of troponin I and phospholamban during catecholamine stimulation of rabbit heart
22. 2+- ATPase activity in guinea pig ventricles
23. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of β-agonist stimulation
24. Phospholamban gene dosage effects in the mammalian heart
25. Compensatory mechanisms associated with the hyperdynamic function of phospholamban-deficient mouse hearts
26. 2+
27. Cardiac myocyte calcium transport in phospholamban knockout mouse: Relaxation and endogenous CaMKII effects
28. Calcium sparks and excitation contraction coupling in phospholamban- deficient mouse ventricular myocytes
29. Regulatory effects of phospholamban on cardiac function in intact mice
30. In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency
31. Thyroid hormone-induced alterations in phospholamban-deficient mouse hearts
32. 2+ channels in mouse ventricular myocytes
33. Phospholamban deficiency does not compromise exercise capacity
34. Effects of age on the hyperdynamic cardiac function of phospholamban knockout mice
35. Targeted ablation of the phospholamban gene is associated with a marked decrease in sensitivity in aortic smooth muscle
36. Transgenic approaches to define the functional role of dual site phospholamban phosphorylation
37. A leucine zipper stabilizes the pentameric membrane domain of phospholamban and forms a coiled-coil pore structure
38. 2+-ATPase isoform of cardiac sarcoplasmic reticulum
39. Pentameric assembly of phospholamban facilitates inhibition of cardiac function in vivo
40. 2+ transport and contractility
41. 2+ channel currents in mouse atrial myocytes
42. 2+ binding effects on protein conformation and protein interactions of canine cardiac calsequestrin
43. The structure of calsequestrin in triads of vertebrate skeletal muscle: A deep-etch study
44. Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane
45. Sarcoplasmic reticulum calsequestrins: Structural and functional properties
46. Cardiac-spe-cific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice
47. 2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin
48. Calsequestrin overexpression produces left ventricular hypertrophy and increased fractional shortening
49. Progressive dilated cardiomyopathy in transgenic mice with calsequestrin overexpression
50. 2+ signaling and spark formation in transgenic myocytes overexpressing calsequestrin
51. Cardiac phenotype of transgenic mice overexpressing calsequestrin
52. Transgenic overexpression of calsequestrin produces pulsus alternans in vivo
53. Rescue of the depressed contractile parameters in calsequestrin overexpressing hearts by phospholamban ablation
54. Intracellular calcium-release channels: Regulators of cell life and death
55. Formation of junctions involved in excitation-contraction coupling in skeletal and cardiac muscle
56. FK506 binding protein associated with the calcium release channel (ryanodine receptor)
57. Selective binding of FKBP12.6 by the cardiac ryanodine receptor
58. 2+ transients in rat cardiac myocytes
59. 2+ release channel closure in rat heart
60. Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein
61. Biochemical characterization and molecular cloning of cardiac triadin
62. Embryonic lethality and abnormal cardiac myocytes in mice lacking ryanodine receptor type 2
63. Functional nonequality of the cardiac and skeletal ryanodine receptors
64. Enhanced dihydropyridine receptor channel activity in the presence of ryano dine receptor
65. Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12
66. 2+ sparks and coupled gating of ryanodine receptors in prenatal FKBP12 knockout mouse cardiac myocytes
67. Structural alterations in cardiac calcium release units resulting from overepression of junctin
68. 2+ pump of the plasma membrane
69. 2+ pump. A study using specific antibodies
70. Overexpression of the sarcolemmal calcium pump in the myocardium of transgenic rats
71. Relaxation in rabbit and rat cardiac cells: Species-dependent differences in cellular mechanisms
72. 2+-ATPase in myogenic cells
73. The effect of the internal sodium concentration on calcium fluxes in isolated guinea-pig auricles
74. The control of Ca release from the cardiac sarcoplasmic reticulum: Regulation versus autoregulation
75. Na-Ca exchange and Ca fluxes during contraction and relaxation in mammalian ventricular muscle
76. 2+ exchanger
77. 2+](i) transients in murine ventricular myocytes
78. 2+ exchanger
79. 2+ exchanger gene, NCX1
80. Specific inhibition of Na-Ca exchange function by antisense oligodeoxynucleotides
81. 2+ exchange in neonatal rat heart cells: Antisense inhibition and protein half-life
82. 2+ exchanger
83. +-channel agonist without sarcoplasmic reticulum protein changes in transgenic mice
84. 2+ exchanger increases susceptibility to ischemia/reperfusion injury in male, but not female, transgenic mice
85. Kinetics of [Ca](i) decline in cardiac myocytes depend on peak [Ca](i)